Emily C. Brantley, Ph.D.

2007 University of Alabama, Birmingham, Birmingham, AL, United States 
"Emily Brantley"
Mean distance: 21.25 (cluster 6)


Sign in to add mentor
Etty N. Benveniste grad student 2007 UAB
 (Loss of PIAS3 expression in glioblastoma multiforme tumors: Implications for STAT-3 activation and gene expression.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sestero CM, McGuire DJ, De Sarno P, et al. (2012) CD5-dependent CK2 activation pathway regulates threshold for T cell anergy. Journal of Immunology (Baltimore, Md. : 1950). 189: 2918-30
Kim SJ, Kim JS, Kim SW, et al. (2012) Antivascular therapy for multidrug-resistant ovarian tumors by macitentan, a dual endothelin receptor antagonist Translational Oncology. 5: 39-47
Zigler M, Kamiya T, Brantley EC, et al. (2011) PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis. Cancer Research. 71: 6561-6
Kim SJ, Kim JS, Kim SW, et al. (2011) Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer Neoplasia. 13: 167-179
Brantley EC, Guo L, Zhang C, et al. (2010) Nitric oxide-mediated tumoricidal activity of murine microglial cells. Translational Oncology. 3: 380-8
Langley RR, Fan D, Guo L, et al. (2009) Generation of an immortalized astrocyte cell line from H-2Kb-tsA58 mice to study the role of astrocytes in brain metastasis. International Journal of Oncology. 35: 665-72
Brantley EC, Nabors LB, Gillespie GY, et al. (2008) Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4694-704
Brantley EC, Benveniste EN. (2008) Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Molecular Cancer Research : McR. 6: 675-84
See more...